Literature DB >> 33486621

Tics in patients with encephalitis.

James Badenoch1, Tamara Searle1, Iona Watson1, Andrea E Cavanna2,3,4.   

Abstract

BACKGROUND: Movement disorders have been described in the context of different types of encephalitis. Among hyperkinetic manifestations, tics have sporadically been reported in cases of encephalitis resulting from a range of aetiologies.
OBJECTIVE: This review aimed to assess the prevalence and characteristics of tics in patients with encephalitis.
METHODS: We conducted a systematic literature review of original studies on the major scientific databases, according to the standards outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
RESULTS: In addition to the established association between tics and encephalitis lethargica, our literature search identified reports of tics in patients with immune-mediated pathologies (including autoimmune encephalitides affecting the N-methyl-D-aspartate receptor, voltage-gated potassium channels, and glycine receptors) and infective processes (ranging from relatively common viral pathogens, such as herpes simplex, to prions, as in Creutzfeldt-Jakob disease). Tics were most commonly reported in the post-encephalitic period and involvement of the basal ganglia was frequently observed. DISCUSSION: The association of new-onset tics and encephalitis, in the background of other neuropsychiatric abnormalities, has practical implications, potentially improving the detection of encephalitis based on clinical features. Future research should focus on the categorisation and treatment of hyperkinetic movement disorders associated with encephalitis.

Entities:  

Keywords:  Encephalitis; Gilles de la Tourette syndrome; Hyperkinetic movement disorders; Tics

Mesh:

Year:  2021        PMID: 33486621      PMCID: PMC7955972          DOI: 10.1007/s10072-021-05065-w

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  59 in total

1.  Encephalitis lethargica with quick response to immunoglobulin.

Authors:  Sotirios Maranis; Sofia Tsouli; Athanasios P Kyritsis
Journal:  Clin Neuropharmacol       Date:  2010 Nov-Dec       Impact factor: 1.592

2.  Spectrum of movement disorders in encephalitis.

Authors:  U K Misra; J Kalita
Journal:  J Neurol       Date:  2010-07-17       Impact factor: 4.849

Review 3.  Are antibasal ganglia antibodies important, and clinically useful?

Authors:  Davide Martino; Andrew Church; Gavin Giovannoni
Journal:  Pract Neurol       Date:  2007-02

4.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

Review 5.  Encephalitis lethargica: 100 years after the epidemic.

Authors:  Leslie A Hoffman; Joel A Vilensky
Journal:  Brain       Date:  2017-08-01       Impact factor: 13.501

6.  Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.

Authors:  Julia Granerod; Helen E Ambrose; Nicholas Ws Davies; Jonathan P Clewley; Amanda L Walsh; Dilys Morgan; Richard Cunningham; Mark Zuckerman; Ken J Mutton; Tom Solomon; Katherine N Ward; Michael Pt Lunn; Sarosh R Irani; Angela Vincent; David Wg Brown; Natasha S Crowcroft
Journal:  Lancet Infect Dis       Date:  2010-10-15       Impact factor: 25.071

7.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.

Authors:  Russell C Dale; Vera Merheb; Sekhar Pillai; Dongwei Wang; Laurence Cantrill; Tanya K Murphy; Hilla Ben-Pazi; Sophia Varadkar; Tim D Aumann; Malcolm K Horne; Andrew J Church; Thomas Fath; Fabienne Brilot
Journal:  Brain       Date:  2012-10-11       Impact factor: 13.501

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies.

Authors:  Mark J Edwards; Russell C Dale; Andrew J Church; Eleni Trikouli; Niall P Quinn; Andrew J Lees; Gavin Giovannoni; Kailash P Bhatia
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338

10.  Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.

Authors:  Russell C Dale; Andrew J Church; Robert A H Surtees; Andrew J Lees; Jane E Adcock; Brian Harding; Brian G R Neville; Gavin Giovannoni
Journal:  Brain       Date:  2003-10-21       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.